{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:55:16Z","timestamp":1761486916005,"version":"3.29.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Pharmacol"],"published-print":{"date-parts":[[2002,6,1]]},"DOI":"10.1124\/mol.61.6.1359","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T23:12:39Z","timestamp":1042672359000},"page":"1359-1365","source":"Crossref","is-referenced-by-count":9,"title":["Inhibition of the Tax-Dependent Human T-Lymphotropic Virus Type I Replication in Persistently Infected Cells by the Fluoroquinolone Derivative K-37"],"prefix":"10.1016","volume":"61","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ichi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2002,6,1]]},"reference":[{"key":"2019081414082109000_61.6.1359.1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/AAC.41.6.1250","article-title":"Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives.","volume":"41","author":"Baba","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2019081414082109000_61.6.1359.2","first-page":"1097","article-title":"Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.","volume":"53","author":"Baba","year":"1998","journal-title":"Mol Pharmacol"},{"key":"2019081414082109000_61.6.1359.3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.162.3.1765","article-title":"Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2\/Tax 11\u201319 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.","volume":"162","author":"Bieganowska","year":"1999","journal-title":"J Immunol"},{"key":"2019081414082109000_61.6.1359.4","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"2019081414082109000_61.6.1359.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.2990037"},{"key":"2019081414082109000_61.6.1359.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.2992082"},{"key":"2019081414082109000_61.6.1359.7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.8.2277"},{"key":"2019081414082109000_61.6.1359.8","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/JVI.63.8.3234-3239.1989","article-title":"A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements.","volume":"63","author":"Fujisawa","year":"1989","journal-title":"J Virol"},{"key":"2019081414082109000_61.6.1359.9","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/JVI.65.8.4525-4528.1991","article-title":"The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation.","volume":"65","author":"Fujisawa","year":"1991","journal-title":"J Virol"},{"key":"2019081414082109000_61.6.1359.10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.","volume":"8452","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"2019081414082109000_61.6.1359.11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JVI.65.3.1628-1633.1991","article-title":"HTLV-I expression in fresh PBMC from patients with TSP\/HAM.","volume":"65","author":"Gessain","year":"1991","journal-title":"J Virol"},{"key":"2019081414082109000_61.6.1359.12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant tax protein expression in CD4+ T cells infected with HTLV-I is prevented by cytotoxic T lymphocytes.","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"2019081414082109000_61.6.1359.13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.14.6395"},{"key":"2019081414082109000_61.6.1359.14","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/j.1460-2075.1986.tb04583.x","article-title":"Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I.","volume":"5","author":"Inoue","year":"1986","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"2019081414082109000_61.6.1359.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3848"},{"key":"2019081414082109000_61.6.1359.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.14.5620"},{"key":"2019081414082109000_61.6.1359.17","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90215-7"},{"key":"2019081414082109000_61.6.1359.18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1099\/0022-1317-78-5-1007","article-title":"AZT inhibits the transmission of human T cell leukemia\/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.","volume":"78","author":"Macchi","year":"1997","journal-title":"J Gen Virol"},{"key":"2019081414082109000_61.6.1359.19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1172\/JCI113085","article-title":"Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.","volume":"80","author":"Matsushita","year":"1987","journal-title":"J Clin Investig"},{"key":"2019081414082109000_61.6.1359.20","doi-asserted-by":"publisher","DOI":"10.1038\/294770a0"},{"key":"2019081414082109000_61.6.1359.21","first-page":"219","article-title":"Type C virus-producing cell lines derived from adult T cell leukemia.","volume":"28","author":"Miyoshi","year":"1982","journal-title":"Gann Monogr"},{"key":"2019081414082109000_61.6.1359.22","first-page":"752","article-title":"Detection of pX proteins in human T-cell leukemia virus (HTLV-I)-infected cells by using antibody against peptide deduced from sequences of X-IV DNA of HTLV-I and Xc DNA of HTLV-II proviruses.","volume":"75","author":"Miwa","year":"1984","journal-title":"Gann"},{"key":"2019081414082109000_61.6.1359.23","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809114225"},{"key":"2019081414082109000_61.6.1359.24","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0396"},{"key":"2019081414082109000_61.6.1359.25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/AAC.43.3.492","article-title":"Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.","volume":"43","author":"Okamoto","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2019081414082109000_61.6.1359.26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/aid.1998.14.1239","article-title":"Potent inhibition of HIV type 1 replication by an anti-inflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.","volume":"14","author":"Okamoto","year":"1998","journal-title":"AIDS Res Hum Retrovir"},{"key":"2019081414082109000_61.6.1359.27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity.","volume":"8848","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"2019081414082109000_61.6.1359.28","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(88)90134-6"},{"key":"2019081414082109000_61.6.1359.29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"2019081414082109000_61.6.1359.30","doi-asserted-by":"publisher","DOI":"10.1126\/science.6091270"},{"key":"2019081414082109000_61.6.1359.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1990.tb02554.x"},{"key":"2019081414082109000_61.6.1359.32","unstructured":"Takatsuki K Uchiyama T Sagawa K Yodoi J (1977) Adult T cell leukemia in Japan. in Topics in Hematology. Proceedings of the 16th International Congress of Hematology; 1976; Kyoto, Japan, eds Seno S Takaku F Irino S (Excerpta Medica, Amsterdam), p 73."},{"key":"2019081414082109000_61.6.1359.33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00042560-199910010-00014","article-title":"Molecular pathologic analysis of the tonsil in HTLV-I-infected individuals.","volume":"22","author":"Takenouchi","year":"1999","journal-title":"J Aquir Immune Defic Syndr"},{"key":"2019081414082109000_61.6.1359.34","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1128\/JVI.73.12.10289-10295.1999","article-title":"Effect of lamivudine on human T-cell leukemia virus type I (HTLV-I) DNA copy number, T-cell phenotype and anti-tax cytotoxic T-cell frequency in patients with HTLV-I-associated myelopathy.","volume":"73","author":"Taylor","year":"1999","journal-title":"J Virol"},{"key":"2019081414082109000_61.6.1359.35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/095632029800900504","article-title":"Broad-spectrum antiviral activity and mechenism of antiviral action of the fluoroquinolone derivative K-12.","volume":"9","author":"Witvrouw","year":"1998","journal-title":"Antiviral Chem Chemother"},{"key":"2019081414082109000_61.6.1359.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2031"},{"key":"2019081414082109000_61.6.1359.37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.05.040187.002545"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.61.6.1359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:35:32Z","timestamp":1732732532000},"score":1,"resource":{"primary":{"URL":"http:\/\/molpharm.aspetjournals.org\/lookup\/doi\/10.1124\/mol.61.6.1359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2002,6,1]]},"published-print":{"date-parts":[[2002,6,1]]}},"alternative-id":["10.1124\/mol.61.6.1359"],"URL":"https:\/\/doi.org\/10.1124\/mol.61.6.1359","relation":{},"ISSN":["0026-895X","1521-0111"],"issn-type":[{"type":"print","value":"0026-895X"},{"type":"electronic","value":"1521-0111"}],"subject":[],"published":{"date-parts":[[2002,6,1]]}}}